Imexpharm Corp.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -8.06% vs 20.96% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 5.83% vs 31.19% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "546,206.30",
          "val2": "594,058.50",
          "chgp": "-8.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129,431.20",
          "val2": "125,994.10",
          "chgp": "2.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,476.20",
          "val2": "2,206.00",
          "chgp": "12.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "73,070.40",
          "val2": "69,047.80",
          "chgp": "5.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "189.80%",
          "val2": "168.00%",
          "chgp": "2.18%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.70% vs 10.59% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 2.30% vs 16.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,441,085.50",
          "val2": "2,205,119.90",
          "chgp": "10.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "567,153.40",
          "val2": "520,794.50",
          "chgp": "8.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16,501.40",
          "val2": "3,590.40",
          "chgp": "359.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "304,389.30",
          "val2": "297,535.70",
          "chgp": "2.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "189.40%",
          "val2": "188.30%",
          "chgp": "0.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

546,206.30

594,058.50

-8.06%

Operating Profit (PBDIT) excl Other Income

129,431.20

125,994.10

2.73%

Interest

2,476.20

2,206.00

12.25%

Exceptional Items

0.00

0.00

Consolidate Net Profit

73,070.40

69,047.80

5.83%

Operating Profit Margin (Excl OI)

189.80%

168.00%

2.18%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -8.06% vs 20.96% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 5.83% vs 31.19% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,441,085.50

2,205,119.90

10.70%

Operating Profit (PBDIT) excl Other Income

567,153.40

520,794.50

8.90%

Interest

16,501.40

3,590.40

359.60%

Exceptional Items

0.00

0.00

Consolidate Net Profit

304,389.30

297,535.70

2.30%

Operating Profit Margin (Excl OI)

189.40%

188.30%

0.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 10.70% vs 10.59% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 2.30% vs 16.85% in Dec 2024

All Annual Results